NuCISION is a startup innovative BioMedical company that has developed a process for killing Single Strand RNA Viruses.
COVID-19 is a a Single Strand RNA Virus.
The World’s First Nano-guided Antiviral Designed to Target SARS-CoV-2 Inside the Cell
A completely novel therapeutic approach.
New method of drug delivery that uses synthetically assembled molecules.
It transport a proven virus killer enzyme into the cell thus targeting SARS-CoV-2 where it reproduces.
Previous antivirals unable to do this getting stuck OUTSIDE the cell; resulting in limited effectiveness.
First INTRACELLULAR and TARGETED treatment.
Promises high specificity, effectiveness.
Less toxicity based on the approach.
> We have completed the patent application.
> We are completing creation of the of the material.
> We are about to enter Animal Testing (July).
> We are pre-approved for Stage 1 and 2 Clinical Trials.
So far we have achieved this in record time and without raising money.
We are now looking for support to enable us to complete Animal Testing of this most crucial technology.
Please help us complete this life saving mission.
Your donation matters